Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia

References

• Australian Institute of Health and Welfare. Cancer in Australia: an overview, 2006. Canberra: Australian Institute of Health and Welfare; 2007.
   Google Scholar
• The Cancer Council Victoria. Cancer in Victoria 2004. Melbourne: Cancer Epidemiology Centre, The Cancer Council Victoria; 2006.
   Google Scholar
• National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982;49:2112–2135.
   PubMed Web of Science ®Google Scholar
• Lennert K, Feller A. Histopathology of non-Hodgkin's lymphomas, 2nd ed. New York: Springer-Verlag; 1992.
   Google Scholar
• Harris NL, Jaffe ES, Stein H, et al A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361–1392.
   PubMed Web of Science ®Google Scholar
• Bennett JM, Catovsky D, Daniel MT, et al Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451–458.
   PubMed Web of Science ®Google Scholar
• Bennett JM, Catovsky D, Daniel MT, et al Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189–199.
   PubMed Web of Science ®Google Scholar
• Harris NL, Jaffe ES, Diebold J, et al World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting – Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835–3849.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al World Health Organization classification of tumours of haematopoietic and lymphoid tissues, 4th ed. Lyon: IARC Press; 2008.
   Google Scholar
• Fritz A. International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization; 2000.
   Google Scholar
• Australian Blood Cancer Registry. Report of the third annual stakeholder meeting, Stamford Plaza Sydney Airport, 11 October 2007. Sydney: ABCR; 2008.
   Google Scholar
• International Agency for Research on Cancer. International rules for multiple primary cancers (ICD-O Third edition). Internal Report No. 2004/02. Lyon: IARC; 2004 [cited 26 September 2008]. Available from: http://www.iarc.com.fr/MPrules_July2004.pdf
   Google Scholar
• Australian Bureau of Statistics [cited 7 November 2008]. Available from: http://www.abs.gov.au/
   Google Scholar
• Waterhouse J, Muir C, Shanmugaratnam K, Powell J. Cancer incidence in five continents. Vol. IV. IARC scientific publications no 42. Lyon: International Agency for Research on Cancer; 1982.
   Google Scholar
• English D, Farrugia H, Thursfield V, Chang P, Giles G. Cancer Survival Victoria 2007: estimates of survival in 2004 (and comparisons with earlier periods). Melbourne: Victorian Cancer Registry, Cancer Epidemiology Centre, The Cancer Council Victoria; 2007.
   Google Scholar
• Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335–51 [Erratum in: Stat Med 2001;20:655].
   PubMed Web of Science ®Google Scholar
• Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996;78:2004–2010.
   PubMed Web of Science ®Google Scholar
• Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961;6:101–121.
   PubMedGoogle Scholar
• Ederer F, Heise H. Methodological note no. 10, end results evaluation section. In: Instructions to IBM 650 programmers in processing survival computations. Bethesda, MD: National Cancer Institute; 1959.
   Google Scholar
• Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51–64.
   PubMed Web of Science ®Google Scholar
• Stata statistical software: release 10. College Station, TX: StataCorp LP; 2007.
   Google Scholar
• Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 2006;107:265–276.
   PubMed Web of Science ®Google Scholar
• Luminari S, Cesaretti M, Rashid I, et al Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. Hematol Oncol 2007;25:189–197.
   PubMed Web of Science ®Google Scholar
• Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer 2007;109:1536–1542.
   PubMed Web of Science ®Google Scholar
• Rawstron AC, Green MJ, Kuzmicki A, et al Monoclonal B lymphocytes with the characteristics of “chronic” lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002;100:635–639.
   PubMed Web of Science ®Google Scholar
• Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005;84:1–12.
   PubMed Web of Science ®Google Scholar
• Adamson P, Bray F, Constantini AS, Tao MH, Weiderpass E, Roman E. Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer 2007;43:391–401.
   PubMed Web of Science ®Google Scholar
• Phekoo KJ, Richards MA, Moller H, Schey SA. The incidence and outcome of myeloid malignancies in 2,112 adult patients in South East-England. Haematologica 2006;91:1400–1404.
   PubMed Web of Science ®Google Scholar
• Deschler B, Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer 2006;107:2099–2107.
   PubMed Web of Science ®Google Scholar
• Ries LAG, Melbert D, Krapcho M, et al SEER cancer statistics review, 1975–2005. Bethesda, MD: National Cancer Institute [cited 26 September 2008]. Available from: http://seer.cancer.gov/csr/1975_2005/
   Google Scholar
• Germin U, Aul C, Niemeyer CM, Haas R, Bennett JM. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes. Ann Hematol 2008;87:691–699.
   PubMed Web of Science ®Google Scholar
• Sant M, Aareleid T, Berrino F, et al Eurocare-3: survival of cancer patients diagnosed 1990–94 – results and commentary. Ann Oncol 2003;14(Suppl. 5):v61–118.
   PubMed Web of Science ®Google Scholar
• Allemani C, Sant M, De Angelis R, Marcos-Gragera R, Coeberg JW. Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups. Cancer 2006;107:352–360.
   PubMed Web of Science ®Google Scholar
• Clarke CA, Glaser SL, Prehn AW. Age-specific survival after Hodgkin's disease in a population-based cohort (United States). Cancer Causes Control 2001;12:803–812.
   PubMed Web of Science ®Google Scholar
• Erdkamp FL, Breed WP, Bosch LJ, Wijnen JT, Blijham GB. Hodgkin disease in the elderly. A registry-based analysis. Cancer 1992;5:830–834.
   Web of Science ®Google Scholar
• Wedelin C, Bjorkholm M, Biberfeld P, Holm G, Johansson B, Mellstedt H. Prognostic factors in Hodgkin's disease with special reference to age. Cancer 1984;53:1202–1208.
   PubMed Web of Science ®Google Scholar
• Armstrong AA, Alexander FE, Cartwright R, et al Epstein- Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia 1998;12:1272–1276.
   PubMed Web of Science ®Google Scholar
• Groves F, Linet M, Travis L, Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000;92:1240–1251.
   PubMed Web of Science ®Google Scholar
• A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997;89:3909–3918.
   PubMed Web of Science ®Google Scholar
• Clarke CA, Glaser SL, Dorfman RF, Bracci PM, Eberle E, Holly EA. Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications. Cancer Epidemiol Biomarkers Prev 2004;13:138–143.
   PubMed Web of Science ®Google Scholar
• Howe RB, Porwit-MacDonald A, Wanat R, Tehranchi R, Hellström-Lindberg E. The WHO classification of MDS does make a difference. Blood 2004;103:3265–3270.
   PubMed Web of Science ®Google Scholar